Cytosorbents Corp (NASDAQ:CTSO)

7.90
Delayed Data
As of Feb 23
 +0.05 / +0.64%
Today’s Change
3.30
Today|||52-Week Range
8.10
+21.54%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close7.85
Today’s open8.05
Day’s range7.80 - 8.05
Volume176,770
Average volume (3 months)145,760
Market cap$226.7M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-42.42%
Earnings growth (this year)+45.21%
Earnings growth (next 5 years)--
Revenue growth (last year)+98.84%
P/E ratioNM
Price/Sales14.55
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CDXCChromadex Corp+0.06+1.14%
NVLNNovelion Therapeutic...+0.11+2.64%
CDTXCidara Therapeutics ...-0.15-2.24%
NATRNatures Sunshine Pro...+0.10+0.86%
Data as of 4:00pm ET, 02/23/2018

Financials

Next reporting dateApril 3, 2018
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$9.5M
Annual profit (last year)-$11.9M
Net profit margin-125.31%

Profile

Sector
Health Technology
Industry
Medical Specialties
President Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent J. Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts